Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion type Assertion NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_head.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion description "[Treatment of a BRAF-mutant/phosphatase and tensin homologue (PTEN) null melanoma cell line with vemurafenib led to decreased phosphorylation of ERK, phospholipase C1, and ?-catenin with increases in receptor tyrosine kinase phosphorylation, signal transduction and activator of signaling 3, and glycogen synthase kinase 3? noted.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_provenance.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion evidence source_evidence_literature NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_provenance.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion SIO_000772 25339196 NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_provenance.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion wasDerivedFrom befree-2016 NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_provenance.
- NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_assertion wasGeneratedBy ECO_0000203 NP1231898.RAliVLfSGZ1pIqWA0FFFzd1t7ayFmZbqPG86FkcWyDpB4130_provenance.